1. Home
  2. PJT vs XENE Comparison

PJT vs XENE Comparison

Compare PJT & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PJT Partners Inc.

PJT

PJT Partners Inc.

HOLD

Current Price

$152.26

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$56.02

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PJT
XENE
Founded
2014
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
5.3B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
PJT
XENE
Price
$152.26
$56.02
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$178.50
$68.55
AVG Volume (30 Days)
321.5K
770.1K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
0.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,713,671,000.00
$311,000.00
Revenue This Year
$11.12
N/A
Revenue Next Year
$9.98
$2,496.48
P/E Ratio
$23.03
N/A
Revenue Growth
14.77
N/A
52 Week Low
$127.73
$28.19
52 Week High
$195.62
$62.91

Technical Indicators

Market Signals
Indicator
PJT
XENE
Relative Strength Index (RSI) 51.59 51.36
Support Level $127.73 $52.55
Resistance Level $186.13 $56.66
Average True Range (ATR) 5.51 1.86
MACD -0.74 -0.59
Stochastic Oscillator 27.81 40.58

Price Performance

Historical Comparison
PJT
XENE

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services, and others. Geographically, it generates maximum revenue from the United States, followed by the United Kingdom and other markets.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: